1
/
of
1
Elabscience
SKU:PKSV030278
Recombinant 2019-nCoV S1 Protein (C-10His)
Recombinant 2019-nCoV S1 Protein (C-10His)
Regular price
$260.00 USD
Regular price
Sale price
$260.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant 2019-nCoV S1 Protein (C-10His), a cutting-edge product meticulously designed to cater to the needs of scientific research and diagnostic applications. This protein, derived from the novel coronavirus strain 2019-nCoV, holds immense potential in unraveling the mysteries surrounding this global health concern.
Crafted through advanced recombinant technology, the Recombinant 2019-nCoV S1 Protein (C-10His) exhibits exceptional purity and stability, ensuring reliable and reproducible results in various experimental settings. With its high affinity for the angiotensin-converting enzyme 2 (ACE2) receptor, this protein serves as a valuable tool for investigating viral entry mechanisms and facilitating the development of potential therapeutic interventions.
The Recombinant 2019-nCoV S1 Protein (C-10His) boasts a unique C-terminal 10-His tag, enabling facile purification and detection through affinity chromatography and Western blotting techniques. This feature enhances experimental efficiency, allowing researchers to focus on their scientific inquiries without compromising on accuracy or time.
Furthermore, this product adheres to stringent quality control measures, ensuring batch-to-batch consistency and minimizing any potential variability. Each vial of Recombinant 2019-nCoV S1 Protein (C-10His) is meticulously characterized, guaranteeing its integrity and functionality, thus instilling confidence in its application within the scientific community.
In summary, the Recombinant 2019-nCoV S1 Protein (C-10His) stands as a remarkable tool in the fight against the 2019-nCoV pandemic. Its exceptional purity, stability, and affinity for the ACE2 receptor make it an invaluable asset for unraveling the intricate mechanisms of viral entry and aiding in the development of effective therapeutic strategies. With its reliable performance and stringent quality control, this protein is poised to revolutionize scientific research and diagnostic applications in the quest to combat this global health crisis.
Crafted through advanced recombinant technology, the Recombinant 2019-nCoV S1 Protein (C-10His) exhibits exceptional purity and stability, ensuring reliable and reproducible results in various experimental settings. With its high affinity for the angiotensin-converting enzyme 2 (ACE2) receptor, this protein serves as a valuable tool for investigating viral entry mechanisms and facilitating the development of potential therapeutic interventions.
The Recombinant 2019-nCoV S1 Protein (C-10His) boasts a unique C-terminal 10-His tag, enabling facile purification and detection through affinity chromatography and Western blotting techniques. This feature enhances experimental efficiency, allowing researchers to focus on their scientific inquiries without compromising on accuracy or time.
Furthermore, this product adheres to stringent quality control measures, ensuring batch-to-batch consistency and minimizing any potential variability. Each vial of Recombinant 2019-nCoV S1 Protein (C-10His) is meticulously characterized, guaranteeing its integrity and functionality, thus instilling confidence in its application within the scientific community.
In summary, the Recombinant 2019-nCoV S1 Protein (C-10His) stands as a remarkable tool in the fight against the 2019-nCoV pandemic. Its exceptional purity, stability, and affinity for the ACE2 receptor make it an invaluable asset for unraveling the intricate mechanisms of viral entry and aiding in the development of effective therapeutic strategies. With its reliable performance and stringent quality control, this protein is poised to revolutionize scientific research and diagnostic applications in the quest to combat this global health crisis.
Share
